MSD eyeing Seagen acquisition, media reports
![Photo: MSD / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14161287.ece/ALTERNATES/schema-16_9/doc7lh8tke7jopl22tv9hm.jpg)
Pharmaceutical firm MSD is reported interested in buying US-based biotech firm Seagen, anonymous sources have told media Dow Jones News.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
MSD stops prostate cancer trial
For subscribers